Role of glycoprotein Ibα mobility in platelet function

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-11-0751
Issue:2010: 103/5 (May) pp. 875–1108
Pages:1033-1043

Role of glycoprotein Ibα mobility in platelet function

D. E. van der Wal (1), S. Verhoef (1), R. E. G. Schutgens (2), M. Peters (3), Y. Wu (1), J. W. N. Akkerman (1)

(1) Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands; (2) Department of Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands; (3) Department of Pediatric-Haematology, Emma Childrens Hospital, Academic Medical Center Amsterdam

Summary

Incubation at 0°C is known to expose b- N -acetyl-D-glucosamine residues on glycoprotein (GP) Ibα inducing receptor clustering and αMβ2-mediated platelet destruction by macrophages. Here we show that incubation at 0/37°C (4 hours at 0°C, followed by 1 hour at 37°C to mimic cold-storage and post-transfusion conditions) triggers a conformational change in the N -terminal flank (NTF, amino acids, aa 1–35) but not in aa 36–282 of GPIbα as detected by antibody binding. Addition of the sugar N -acetyl-D-glucosamine (GN) inhibits responses induced by 0/37°C. Incubation at 0°C shifts GPIbα from the membrane skeleton to the cytoskeleton. Different GPIbα conformations have little effect on VWF/ristocetin-induced aggregation, but arrest of NTF change by GN interferes with agglutination and spreading on a VWF-coated surface under flow. Strikingly, incubation at 0/37°C initiates thromboxane A2 formation through a von Willebrand factor (VWF)-independent and GPIbα-dependent mechanism, as confirmed in VWF- and GPIbα-deficient platelets. We conclude that the NTF change induced by 0/37°C incubation reflects clustering of GPIbα supports VWF/ristocetin-induced agglutination and spreading and is sufficient to initiate platelet activation in the absence of VWF.

Keywords

Platelet, thromboxane A2, cytoskeleton, Glycoprotein Iba, cold-storage

DOI

http://dx.doi.org/10.1160/TH09-11-0751

You may also be interested in...

1.

Marie-Christine Alessi, Irène Juhan-Vague

Thrombosis and Haemostasis 2008 99 6: 995-1000

http://dx.doi.org/10.1160/TH07-11-0682

2.

Charalambos Tymvios1, Sarah Jones1, Christopher Moore1, Simon C. Pitchford1, Clive P. Page2, Michael Emerson1

Thrombosis and Haemostasis 2008 99 2: 435-440

http://dx.doi.org/10.1160/TH07-07-0479

3.

Akifumi Inomo*, Toshitaka Sugi*, Yoshimi Fujita, Hidehiko Matsubayashi, Shun-ichiro Izumi, Mikio Mikami

Thrombosis and Haemostasis 2008 99 2: 316-323

http://dx.doi.org/10.1160/TH07-07-0447



Articles

You've 155 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...